T. Cooley and P. Lee, A series of cases of splenomegaly in children with anemia and peculiar bone changes, 1925.

B. Modell and M. Darlison, Global epidemiology of haemoglobin disorders and derived service indicators, Bull World Health Organ, vol.86, pp.480-487, 2008.

J. Flint, R. M. Harding, A. J. Boyce, and J. B. Clegg, The population genetics of the haemoglobinopathies, Baillières Clin Haematol, vol.6, pp.215-62, 1993.

C. Badens and I. Thuret, Beta-thalassemia major: what is the situation in France?, Rev Prat, vol.59, pp.1048-50, 2009.

I. Thuret, Rapport D'Activité Année 2010-1er semestre 2011. Centre de référence Maladies Rares des Thalassémies, 2011.

B. Giardine, J. Borg, E. Viennas, C. Pavlidis, K. Moradkhani et al., Updates of the HbVar database of human hemoglobin variants and thalassemia mutations, Nucleic Acids Res, vol.42, pp.1063-1072, 2014.

P. Joly, C. Pondarre, and C. Badens,

, Ann Biol Clin (Paris), vol.72, pp.639-68, 2014.

D. R. Higgs, J. D. Engel, G. Stamatoyannopoulos, and . Thalassaemia, Lancet Lond Engl, vol.379, issue.11, pp.60283-60286, 2012.

B. Bonello, Bases moléculaires des syndromes thalassémiques et facteurs génétiques modulateurs de sévérité de la beta-thalassémie. Rev Méditerranéenne Génétique Hum, 2010.

D. J. Weatherall, Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias, Nat Rev Genet, vol.2, pp.245-55, 2001.

R. Galanello and R. Origa, Beta-thalassemia, Orphanet J Rare Dis, vol.5, p.11, 2010.

C. Borgna-pignatti, S. Rugolotto, D. Stefano, P. Zhao, H. Cappellini et al., Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine, Haematologica, vol.89, pp.1187-93, 2004.

J. C. Wood, Cardiac Complications in thalassemia major, Hemoglobin, vol.33, pp.81-87, 2009.

, ALD n° 10-Liste des actes et prestations sur les syndromes thalassémiques majeurs et intermédiaires, HAS, 2009.

D. Rund and . Thalassemia, Modern Medicine Battles an Ancient Disease, Am J Hematol, 2015.

V. Gabutti and A. Piga, Results of long-term iron-chelating therapy, Acta Haematol, vol.95, pp.26-36, 1996.

B. Lacour, Physiologie du rein et bases physiopathologiques des maladies rénales

C. Choremis, K. Kiossoglou, F. Maounis, and B. Basti, Amino-acid tolerance curves and amino-aciduria in Cooley's and sickle-cell anaemias, J Clin Pathol, vol.12, pp.245-53, 1959.

, Agence nationale de sécurité du médicament et des produits de santé. Mise sur le marché d'EXJADE ® (deferasirox) : informations importantes sur le bon usage et la surveillance du traitement. Lettre destinée aux professionnels de santé, 2007.

M. Economou, N. Printza, A. Teli, V. Tzimouli, I. Tsatra et al., Renal Dysfunction in Patients with Beta-Thalassemia Major Receiving Iron Chelation Therapy either with Deferoxamine and Deferiprone or with Deferasirox, Acta Haematol, vol.123, pp.148-52, 2010.

M. Mohkam, B. S. Shamsian, A. Gharib, S. Nariman, and M. T. Arzanian, Early markers of renal dysfunction in patients with beta-thalassemia major, Pediatr Nephrol, vol.23, pp.971-977, 2008.

N. S. Mallat, K. M. Musallam, S. G. Mallat, F. N. Ziyadeh, S. Koussa et al., End stage renal disease in six patients with beta-thalassemia intermedia, Blood Cells Mol Dis, vol.51, pp.146-154, 2013.

C. T. Quinn, V. L. Johnson, H. Kim, F. Trachtenberg, M. G. Vogiatzi et al., Renal dysfunction in patients with thalassaemia, Br J Haematol, vol.153, pp.111-118, 2011.

K. M. Musallam and A. T. Taher, Mechanisms of renal disease in ?-thalassemia, J Am Soc Nephrol, vol.23, pp.1299-302, 2012.

S. Bhandari and R. Galanello, Renal aspects of thalassaemia a changing paradigm, Eur J Haematol, vol.89, pp.187-97, 2012.

A. T. Taher, K. M. Musallam, M. Karimi, A. El-beshlawy, K. Belhoul et al., Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study, Blood, vol.115, pp.1886-92, 2010.

, ALD n° 10-PNDS sur les syndromes thalassémiques majeurs et intermédiaires, HAS, 2008.

I. Thuret,

, Rev Prat, vol.64, pp.1132-1139, 2014.

L. Dubourg, C. Laurain, B. Ranchin, C. Pondarré, A. Hadj-aïssa et al., Deferasirox-induced renal impairment in children: an increasing concern for pediatricians, Pediatr Nephrol Berl Ger, vol.27, pp.2115-2137, 2012.

I. Thuret, C. Pondarré, A. Loundou, D. Steschenko, R. Girot et al., Complications and treatment of patients with ?-thalassemia in France: results of the National Registry, Haematologica, vol.95, pp.724-733, 2010.

M. E. Lai, A. Spiga, S. Vacquer, M. P. Carta, C. Corrias et al., Renal function in patients with-thalassaemia major: a long-term follow-up study, Nephrol Dial Transplant, vol.27, pp.3547-51, 2012.

A. Jalali, H. Khalilian, A. Ahmadzadeh, S. Sarvestani, F. Rahim et al., Renal function in transfusion-dependent pediatric beta-thalassemia major patients, Hematology, vol.16, pp.249-54, 2011.

C. Ponticelli, K. M. Musallam, P. Cianciulli, and M. D. Cappellini, Renal complications in transfusion-dependent beta thalassaemia, Blood Rev, vol.24, pp.239-283, 2010.

J. Yacobovich, P. Stark, S. Barzilai-birenbaum, I. Krause, I. Pazgal et al., Acquired Proximal Renal Tubular Dysfunction in ?-Thalassemia Patients Treated With Deferasirox, J Pediatr Hematol Oncol, vol.32, pp.564-571, 2010.

N. Papadopoulos, A. Vasiliki, G. Aloizos, P. Tapinis, and A. Kikilas, Hyperchloremic Metabolic Acidosis Due to Deferasirox in a Patient with Beta Thalassemia Major, Ann Pharmacother, vol.44, pp.219-240, 2010.

H. Wei, C. Yang, C. Cheng, and F. Lo, Fanconi syndrome in a patient with ?thalassemia major after using deferasirox for 27 months: Fanconi syndrome and deferasirox, Transfusion (Paris), vol.51, pp.949-54, 2011.

F. N. Ziyadeh, K. M. Musallam, N. S. Mallat, S. Mallat, F. Jaber et al., Glomerular Hyperfiltration and Proteinuria in Transfusion-Independent Patients with ßThalassemia Intermedia, Nephron Clin Pract, vol.121, pp.136-179, 2012.

P. Ricchi, M. Ammirabile, S. Costantini, A. Spasiano, D. Matola et al., Nephrolithiasis in patients exposed to deferasirox and desferioxamine: probably an agelinked event with different effects on some renal parameters, Ann Hematol, vol.93, pp.525-532, 2014.

P. Ricchi, M. Ammirabile, S. Costantini, D. Matola, T. Spasiano et al., Splenectomy is a risk factor for developing hyperuricemia and nephrolithiasis in patients with thalassemia intermedia: A retrospective study, Blood Cells Mol Dis, vol.49, pp.133-138, 2012.

V. Matos, G. Van-melle, O. Boulat, M. Markert, C. Bachmann et al., Urinary phosphate/creatinine, calcium/creatinine, and magnesium/creatinine ratios in a healthy pediatric population, J Pediatr, vol.131, pp.252-259, 1997.

M. N. Aloni, R. M. Ngiyulu, J. Gini-ehungu, C. N. Nsibu, M. B. Ekila et al., Renal Function in Children Suffering from Sickle Cell Disease: Challenge of Early Detection in Highly Resource-Scarce Settings, PLoS ONE, vol.9, p.96561, 2014.

J. Haymann, K. Stankovic, P. Levy, V. Avellino, P. Tharaux et al., Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature, Clin J Am Soc Nephrol, vol.5, pp.756-61, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00597593

G. Koliakos, F. Papachristou, A. Koussi, V. Perifanis, I. Tsatra et al., Urine biochemical markers of early renal dysfunction are associated with iron overload in betathalassaemia, Clin Lab Haematol, vol.25, pp.105-114, 2003.

V. Smolkin, R. Halevy, C. Levin, M. Mines, W. Sakran et al., Renal function in children with ?-thalassemia major and thalassemia intermedia, Pediatr Nephrol, vol.23, pp.1847-51, 2008.

C. Dee, D. Cheuk, S. Ha, A. Chiang, and G. Chan, Incidence of deferasiroxassociated renal tubular dysfunction in children and young adults with betathalassaemia, Br J Haematol, vol.167, pp.434-440, 2014.

B. Aldudak, K. Bayazit, A. Noyan, A. Ozel, A. Anarat et al., Renal function in pediatric patients with beta-thalassemia major, Pediatr Nephrol, vol.15, pp.109-121, 2000.

P. Cianciulli, D. Sollecito, F. Sorrentino, L. Forte, E. Gilardi et al., Early detection of nephrotoxic effects in thalassemic patients receiving desferrioxamine therapy, Kidney Int, vol.46, pp.467-70, 1994.

S. Sadeghi-bojd, M. Hashemi, M. Naderi, and S. Shikhani, Kidney function tests in children with beta-thalassemia minor in Zahedan, southeast of Iran, Iran J Kidney Dis, vol.5, pp.201-204, 2011.

H. M. Jafari, K. Vahidshahi, M. Kosaryan, H. Karami, R. Mahdavi et al., Major beta-thalassemia, use of desferiexamine and renal proximal tubular damage, Bratisl Lekárske Listy, vol.112, pp.278-81, 2011.

K. P. Katopodis, M. S. Elisaf, H. A. Pappas, J. C. Theodorou, H. J. Milionis et al., Renal abnormalities in patients with sickle cell-beta thalassemia, J Nephrol, vol.10, pp.163-170, 1997.

E. A. Hamed and N. T. Elmelegy, Renal Functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study, Ital J Pediatr, vol.36, p.39, 2010.
DOI : 10.1186/1824-7288-36-39

URL : https://ijponline.biomedcentral.com/track/pdf/10.1186/1824-7288-36-39?site=ijponline.biomedcentral.com

M. Malaki, R. S. Sorkhabi, M. Shoaran, and B. Shafighe, Beta thalassemia major: the effect of age on glomerular filtration rate, Saudi J Kidney Dis Transplant, vol.22, pp.963-971, 2011.

E. Uzun, Y. I. Balc?, S. Yüksel, Y. Z. Aral, H. Aybek et al., Glomerular and tubular functions in children with different forms of beta thalassemia, Ren Fail, vol.2015, pp.1-5
DOI : 10.3109/0886022x.2015.1077314

G. Milo, F. Gross-nevo, R. Pazgal, I. Gafter-gvili, A. Shpilberg et al., GFR in Patients with ?-Thalassemia Major, Clin J Am Soc Nephrol, vol.10, pp.1350-1356, 2015.
DOI : 10.2215/cjn.12181214

URL : https://cjasn.asnjournals.org/content/10/8/1350.full.pdf

M. H. Fallahzadeh, M. K. Fallahzadeh, M. Shahriari, S. Rastegar, A. Derakhshan et al., Hematuria in patients with Beta-thalassemia major, Iran J Kidney Dis, vol.4, pp.133-139, 2010.

A. Ahmadzadeh, A. Jalali, S. Assar, H. Khalilian, K. Zandian et al., Renal tubular dysfunction in pediatric patients with beta-thalassemia major, Saudi J Kidney Dis Transplant Off Publ Saudi Cent Organ Transplant Saudi Arab, vol.22, pp.497-500, 2011.

M. R. Prabahar, M. Jain, V. Chandrasekaran, E. Indhumathi, and P. Soundararajan, Renal tubular dysfunction with nephrocalcinosis in a patient with beta thalassemia minor, Saudi J Kidney Dis Transplant, vol.19, pp.964-972, 2008.

P. Wong, P. J. Fuller, M. T. Gillespie, V. Kartsogiannis, B. J. Strauss et al., Thalassemia bone disease: the association between nephrolithiasis, bone mineral density and fractures, Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA, vol.24, pp.1965-71, 2013.
DOI : 10.1007/s00198-012-2260-y

E. Fibach and E. Rachmilewitz, The role of oxidative stress in hemolytic anemia, Curr Mol Med, vol.8, pp.609-628, 2008.

M. Nangaku, Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure, J Am Soc Nephrol, vol.17, pp.17-25, 2006.
DOI : 10.1681/asn.2005070757

URL : http://jasn.asnjournals.org/content/17/1/17.full.pdf

L. E. Davis and A. R. Hohimer, Hemodynamics and organ blood flow in fetal sheep subjected to chronic anemia, Am J Physiol, vol.261, pp.1542-1550, 1991.
DOI : 10.1152/ajpregu.1991.261.6.r1542

B. H. Landing, H. C. Gonick, R. L. Nadorra, C. B. Hyman, T. R. Wells et al., Renal lesions and clinical findings in thalassemia major and other chronic anemias with hemosiderosis, Pediatr Pathol Affil Int Paediatr Pathol Assoc, vol.9, pp.479-500, 1989.
DOI : 10.3109/15513818909026908

J. J. Meerpohl, G. Antes, G. Rücker, N. Fleeman, E. Motschall et al., Deferasirox for managing iron overload in people with thalassaemia, Cochrane Database Syst Rev, vol.2, p.7476, 2012.
DOI : 10.1002/14651858.cd007476

URL : http://www.zora.uzh.ch/id/eprint/143432/1/Bollig_Bassler_2017_Neo_USZ.pdf

J. D. Díaz-garcía, A. Gallegos-villalobos, L. Gonzalez-espinoza, M. D. Sanchez-niño, J. Villarrubia et al., Deferasirox nephrotoxicity-the knowns and unknowns, Nat Rev Nephrol, vol.10, pp.574-86, 2014.

, The European Medecines Agency, 2007.

P. D. Sánchez-gonzález, F. J. López-hernandez, A. I. Morales, J. F. Macías-nuñez, and J. M. Lópeznovoa, Effects of deferasirox on renal function and renal epithelial cell death, Toxicol Lett, vol.203, pp.154-61, 2011.

X. Huang, J. J. Thiessen, M. Spino, and D. M. Templeton, Transport of iron chelators and chelates across MDCK cell monolayers: implications for iron excretion during chelation therapy, Int J Hematol, vol.91, pp.401-413, 2010.

F. Tang, K. Horie, and R. T. Borchardt, Are MDCK cells transfected with the human MRP2 gene a good model of the human intestinal mucosa?, Pharm Res, vol.19, pp.773-782, 2002.

T. P. Schaub, J. Kartenbeck, J. König, H. Spring, J. Dörsam et al., Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma, J Am Soc Nephrol, vol.10, pp.1159-69, 1999.

H. Oexle, E. Gnaiger, and G. Weiss, Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation, Biochim Biophys Acta, vol.1413, pp.99-107, 1999.

S. J. Dixon, K. M. Lemberg, M. R. Lamprecht, R. Skouta, E. M. Zaitsev et al., Ferroptosis: an iron-dependent form of nonapoptotic cell death, Cell, vol.149, pp.1060-72, 2012.

Y. Yoon, H. Byun, H. Cho, B. Kim, and G. Yoon, Complex II defect via downregulation of iron-sulfur subunit induces mitochondrial dysfunction and cell cycle delay in iron chelation-induced senescence-associated growth arrest, J Biol Chem, vol.278, pp.51577-86, 2003.

Y. Ikeda, I. Ozono, S. Tajima, M. Imao, Y. Horinouchi et al., Iron Chelation by Deferoxamine Prevents Renal Interstitial Fibrosis in Mice with Unilateral Ureteral Obstruction, PLoS ONE, vol.9, 2014.

F. Deng, G. Finer, S. Haymond, E. Brooks, and C. B. Langman, Applicability of estimating glomerular filtration rate equations in pediatric patients: comparison with a measured glomerular filtration rate by iohexol clearance, Transl Res J Lab Clin Med, vol.165, pp.437-482, 2015.

A. S. Levey, L. A. Stevens, C. H. Schmid, Y. L. Zhang, A. F. Castro et al., A new equation to estimate glomerular filtration rate, Ann Intern Med, vol.150, pp.604-616, 2009.

P. E. Stevens, A. Levin, and K. Disease, Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline, Ann Intern Med, vol.158, pp.825-855, 2013.

B. Deveci, A. Kurtoglu, E. Kurtoglu, O. Salim, and T. Toptas, Documentation of renal glomerular and tubular impairment and glomerular hyperfiltration in multitransfused patients with beta thalassemia, Ann Hematol, 2015.

J. F. Sebestyen and U. S. Alon, The teenager with asymptomatic proteinuria: think orthostatic first, Clin Pediatr, vol.50, pp.179-82, 2011.

M. Mazzoni, L. Kottanatu, G. D. Simonetti, M. Ragazzi, M. G. Bianchetti et al., Renal vein obstruction and orthostatic proteinuria: a review, Nephrol Dial Transplant, vol.26, pp.562-567, 2011.

J. I. Levitt, The prognostic significance of proteinuria in young college students, Ann Intern Med, vol.66, pp.685-96, 1967.

M. Hashemieh, A. Azarkeivan, S. Akhlaghpoor, A. Shirkavand, and K. Sheibani, T2-star (T2*) magnetic resonance imaging for assessment of kidney iron overload in thalassemic patients, Arch Iran Med, vol.15, pp.91-95, 2012.